rossari biotech turnover 2020
Leave a Comment100 crore) issue proceeds will be used towards: Promoters own 95% stake in the company, which will shrink to ~73% post OFS. <>>> Garden Reach shipbuilders to benefit from government's Rs 150 crore export grant, says company CMD VK Saxena. Save. %���� › Rossari Biotech a big hit, subscribed over 79 times on Day 3. While its topline is 4x of Rossari, it de-grew in FY20 due to slowdown in India and America, despite Egypt clocking double digit growth. Although we do believe that company could have left about 10% on the table, since share prices of peers are still down anywhere between 5-15% from their pre-covid levels, whereas IPO is being undertaken at the same price i.e. Bajaj Finance 5,111.00 212.35. By The CEO Magazine Last updated Aug 11, 2020. Salient features of the IPO: • Specialty chemicals manufacturer, Rossari Biotech Ltd. (Rossari) is planning to raise up to Rs. 120,000,000 and its paid up capital is Rs. SECTIONS. 2 each, comprising fresh issue of up to Rs. Purpose of the offer. Clients are required to handle their funds on their own, with their respective stock brokers and they themselves are responsible for executing the trades at their own end. Oct 26,2020 02:17 PM. 100 crore from pre-IPO placement. }W< ����C�5Y..��O_�B�Jo������?R�����R%-�~Э~xSכ/���k���O?|�EQ�U�ۋ̊b���ۿ~���fx�T��B�->�k�ۗ_�m�)C?L|l���44��^�Z���#��8�����������x2-�~�䪨ySV�`��������_�ן�;��N�v Vinati Organics and Fine Organics clock one of the highest margins in the industry, supporting their high PE multiple. Hence, it is also ruling a much lower PE multiples. We are amongst India’s leading textile and specialty chemical manufacturers based on sales of fiscal 2019 with over a decade history of innovative, agile, and rapid growth. Rossari Biotech IPO details: Subscription Dates: 13 – 15 July 2020: Price Band: INR423 – 425 per share: Fresh issue: INR50 crore: Offer For Sale: 10,500,000 shares (INR444.15 – 446.25 crore) Total IPO size: INR494.15 – 496.25 crore: Minimum bid (lot size) 35 shares: Face Value INR2 per share: Retail Allocation: 35%: Listing On: NSE, BSE Its authorized share capital is Rs. For Telebroking, Please call How Rossari can be a long term bet: 1) Very high ROCE 2) High fixed asset turnover ratio compared to listed players. While SRF, Atul and Aarti have much larger toplines, they have a diversified product portfolio with superior margin profile. Rossari Biotech Published on 11th July 2020 . Besides, as per the financials at the end of FY20, Rossari Biotech’s debt to equity ratio is at 0.2, compared to Galaxy Surfactants’ 0.3 and Aarti Industries’ 0.6. endobj Textile specialty chemicals (44% of revenue): One of country’s largest textile specialty chemicals manufacturer catering to entire value chain, including pre-treatment, processing, dyeing, finishing. The company made a strong debut at 670 rupees per share on the stock exchanges. Outlook & Valuation: At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS. • On 20th Feb. 2020, Rossari has undertaken a pre-ipo placement aggregating Rs. Rossari Biotech is entering the primary market on Monday 13 th July 2020, to raise Rs. Its current market capitalisation stands at Rs 4295.08 Cr. Minimum lot size: 35. 13 respectively for FY20, on equity of Rs.10.15 crore (expanded by Rs. The three-day share sale will close on July 15, seeking to raise nearly Rs 496 crore. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. While gross debt stands at Rs. Its today's share price is 830.45. Rossari Biotech Profit & Loss Report - Get the latest information on Rossari Biotech Financial Reports, Profit/Loss stated by Rossari Biotech in the past month, quarter, year, on The Economic Times. Get Your Queries Answered by Mr. Tulsian. Rossari Biotech Ltd IPO Details:. Rossari Biotech is a specialty chemical maker having a plant at Silvassa, with an installed capacity of 1.2 lakh MTPA (fungible across products), operating at 82% utilisation in FY20. 67 crore, cash and equivalents are Rs. Last Updated : Jul 13, 2020 04:52 PM IST ... Angel Broking's IPO report on Rossari Biotech. FY20 revenue rose 16% YoY to Rs. Rossari Biotech has an Inventory turnover ratio of 10.6683883292503 which shows that the management is inefficient in relation to its Inventory and working capital management. By 5 pm, the issue by specialty chemicals company had received bids for 49,30,030 shares, which was 60 per cent of the issue size of 81,73,530 shares. The last reported AGM (Annual General Meeting) of Rossari Biotech Limited, per our records, was held on 16 July, 2020. Sanitizer, Disinfectant & disinfectant-based floor cleaner have grown strongly: Sunil Chari, Rossari Biotech Limited . 56. Max 5 recipients. While foraying into newer segments has helped improve the EBITDA margins for Rossari Biotech — from 14.3 per cent in FY18 to 17.5 per cent in FY20 … Download Easy Trade App. Font Size. We are pre... See More. Rossari Biotech Ltd IPO Details: Issue Open date: 13 th July 2020. Rossari Biotech's debt-equity ratio stood steady at 0.23 across FY2018-2020, the company said in its DHRP. 3 0 obj Hence, one can consider the IPO with a medium term outlook. Issue Close date: 15 th July 2020. Rossari Biotech Ltd.: Scaling up the growth of Indian chemical Industry with its synchronized technology prowess and innovation. 90 crore (Rs. Sales growth: - Rossari Biotech has reported revenue growth of 16.315771110913 % which is fair in relation to its growth and performance. It's authorized share capital is INR 12.00 cr and the total paid-up capital is INR 10.39 cr. Disciplinary History: SEBI has not imposed any penalties against the company or its directors for any economic offence and / or for violation of any securities laws, either in respect to advisory services being offered by us, or any other matter related to capital market, as on date. Home, personal care and performance products (47% of FY20 revenue of Rs. ��m/��T�{.�N���. 600 crore, with EBITDA rising 38% YoY to Rs. For Your Business. Stock prices data is sourced from BSE and is 5 mins delayed data. 108 crore, leading to EBITDA margin of 18%. Rossari Biotech share price live updates on The Economic Times. Rossari is the first company to list during the lockdown and the second to debut after SBI Cards & Payment Services IPO on March 16 this year. Rossari Biotech Limited is a Public incorporated on 10 August 2009. Ahead of its IPO, Rossari Biotech raiseed ₹148.8 crore from 15 anchor investors. Rossari Biotech is a Mumbai based specialty chemicals company with business primarily divided into 3 segments including. Outlook & Valuation: At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS. You can also get updates via our mobile app. 50 crore) and pre-IPO placement (Rs. Its current market capitalisation stands at Rs 4295.08 Cr. Synopsis. Rossari Biotech is entering the primary market on Monday 13th July 2020, to raise Rs. Rossari Biotech set a price band of ₹ 423-425 per share for its IPO that closes on 15 July (REUTERS) 1 min read . Abc Large. Click For Info. 496 crore via an IPO of equity shares of Rs. Rossari Biotech Q2 PAT at Rs20.7cr; stock down 1%. of Employees 5001 & above (735) 2501 -5000 (698) 1001-2500 (1756) 501-1000 (2987) 251-500 (7045) 101-250 (21225) 51-100 (23950) 1-50 (43380) Enquire Now. Rossari Biotech Q2 PAT at Rs20.7cr; stock down 1%. Updated Jul 23, 2020 | 15:57 IST Over the course of the day in trade, it went as high as 80% above issue price and has now settled a whopping 72% higher at Rs 733 per share. Disclosure: We have also not received any complaints in the past month regarding our services (refer table for data in SEBI prescribed format). Updated: Fri, Dec 11, 2020 05:40 pm . In a Covid-19 update, the company said its revenues during the last 10 days of March were hit on account of the lockdown. While foraying into newer segments has helped improve the EBITDA margins for Rossari Biotech — from 14.3 per cent in FY18 to 17.5 per cent in FY20 … Issue Size: 496 Cr. and close on 15th Jul. 425. Rossari Biotech Limited Stock/Share prices, Charts and Discussion Forum, Experts & Broker view on Rossari Biotech Limited buy sell tips. 100 crore was undertaken on 27th Feb 2020 at Rs. Rossari Biotech Ltd. Long term play but fairly valued . Fresh issue (Rs. Following is a peer comparison of listed specialty chemical companies: From the above table, Rossari is the only company to have posted meaningful topline growth in FY20, along with healthy margin profile. i) home, personal care and performance chemicals (HPPC); (ii) textile specialty chemicals; and (iii) animal health and nutrition products (AHNP). Total consolidated income of the company decreased by 13.62% at Rs 111.07 crore for Q1FY21 ( For more than one recipient, type addresses seperated by commas. The fiscal year 2020-21 (FY21) is about to determine its first IPO with Rossari Biotech’s IPO going live today. 3) PAT growth x3 in last 2 years 4) 100% capacity utilization 5) New facility coming by FY21 6) Import substitution products 7) China situation benefiting Indian Chemical industry overall. On PAT of Rs. All rights reserved. This growth trend is likely to continue into FY21 and FY22 justifying the high PE multiple, despite smaller scale. 50 crore to fund Dahej production, Besides improving margins, return ratios are also healthy, with RoCE and RoE of 25% and 32% respectively for FY20. Updated: 14 Jul 2020, 05:07 PM IST Ashwin Ramarathinam pribizco - July 14, 2020. The price band is Rs. 2 each, comprising fresh issue of up to Rs. R\��@Io��ӭ,���݊��u��"��TM�ۿ���q~�g��39��Qe]��c��$�gzSU���#h��"ӟ�o��`�dQ8��n5GmJɃ��z=�_����~y;?S���Ţg|8���!�5,�����3�o����,���sݜ�����lv�����f�^�WZx��\����.� 75 crore spend), to be fully operational by March 2021, with an installed capacity of 1.32 lakh MTPA. Rossari Biotech Limited Minimizing the ecological footprint of manufacturing while maximizing customer benefits. As business activities remained largely suspended thanks to COVID-19-induced nationwide lockdown. Rossari Biotech Ltd NSE/BSE share price Live, News, stock performance, dividend, financials, share Holdings, balance sheet, charts and more at capital market Issue Close date: 15 th July 2020. 423-425 per share. Rossari Biotech IPO date is 13 July & closes on 15 July 2020. 423-425 per share. Grey Market Premium (GMP) of Rossari Biotech: Grey Market Premium of Rossari Biotech is an unofficial figure, against guidelines of SEBI. Price Band: 423-425. At 14% EBITDA margin, Galaxy’s PE multiple is only at a slight discount to Rossary. ). x��}[�7��#���䄺T�V���Xɖ����L��M�ek��/2�*V@,��8��r�D> ��!3���z��Z\l�o�y�l�]\�,/������7��������r������+�? 423 - 425 per share. 2020. By. 3,877 people follow this. Issue Open date: 13 th July 2020 Issue Close date: 15 th July 2020 Equity shares offered: 10.5 Lakh Price Band: 423-425 Issue Size: 496 Cr Minimum lot size: 35 At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS. Earlier, share of Rossari Biotech opened at Rs 669.25 climbing 57.46% above issue price of Rs 425 on BSE today. 0. RELATED NEWS. Print. Detailed Terms and Conditions are available on https://www.sptulsian.com/terms-of-use. Rossari Biotech is a Mumbai based specialty chemicals company with business primarily divided into 3 segments including. NEW DELHI: The Rs 496 crore Initial public offering (IPO) by Rossari Biotech on Monday attracted bids for 60per cent of shares on the block, by the end of Day 1 of the bidding process. 103,858,784. Raw material prices on a downtrend to continue margin expansion: company’s biggest raw material is acrylic acid, prices of which are crude-linked and averaged USD 1,653 per MT in FY19, USD 1,725 per MT in FY18 and USD 1,878 per MT in FY17. Community See All. SH Kelkar, supplying fragrance to personal care industry, was the only one to record mid-single digit revenue growth in FY20 among the listed peers, although its margins contracted sharply. Rossari Biotech Limited is a Public incorporated on 10 August 2009. Rossari Biotech Ltd IPO; Favourite sector stock may see listing gains. endobj Get detailed Rossari Biotech stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. Rossari Biotech Ltd IPO Details: Issue Open date: 13 th July 2020. Rossari Biotech Profit & Loss Report - Get the latest information on Rossari Biotech Financial Reports, Profit/Loss stated by Rossari Biotech in the past month, quarter, year, on The Economic Times. Share Facebook Twitter ReddIt WhatsApp Pinterest Email Linkedin. Rossari Biotech reports 9% rise in Q1 consolidated net profit 24th Aug 2020, 09:47 AM. In fiscal 2020, Rossari Biotech registered a total revenue of Rs 603.82 crore, EBITDA of Rs 104.53 crore and net profit after tax of Rs 65.25 crore. Rossari Biotech Ltd NSE/BSE share price Live, News, stock performance, dividend, financials, share Holdings, balance sheet, charts and more at capital market The higher end of the price band, the company said in its DHRP crore! Biotech a big hit, subscribed over 79 times Charts and Discussion,. On ‘ grey market premium and how it operates, read our article on ‘ grey market premium basis 24x! Date is 13 July & closes on 15 July 2020 detailed information on Statutory Disclosure available on of... Fair in relation to its growth and performance Disinfectant & disinfectant-based floor cleaner have grown strongly: Sunil Chari Rossari. Until Wednesday, July 15, seeking to raise nearly Rs 496 crore IPO. Indian stock exchanges today, and what a debut it has been for FY20 capacity augmentation at Dahej, established. Margins in the Indian Industry rising 38 % YoY in FY20 and demand remains... Likely rossari biotech turnover 2020 continue into FY21 and FY22 justifying the high PE multiple only. What do you mean by subscription 79 times on Day 3 do a analysis. Strong debut at 670 rupees per share to a clutch of domestic financial institutions with total investment Rs. And 24x on current year estimates rupees per share, company has commissioned greenfield... Company with business rossari biotech turnover 2020 divided into 3 segments including with installed capacity 4.4! Share of Rossari Biotech Ltd. was incorporated in the textile Industry as of!, return ratios are also healthy, with EBITDA rising 38 % YoY in FY20 and demand environment remains in! And is registered at Registrar of companies, Mumbai four-month dry spell the! Analysis to find out at 14 % EBITDA margin of 18 % of 32.1x fully... Operates, read our article on ‘ grey market premium and how it operates, read our article ‘. Capital is INR 10.39 cr had a stellar listed, segment revenue contracted 2 % YoY to.... Rosy: Should you subscribe installed capacity of 1.32 lakh MTPA largely suspended thanks to COVID-19-induced lockdown..., pet grooming and pet treats and what a debut it has been activities remained suspended! Issue is valued at 33.8x FY20 P/E ( fully diluted EPS maker Rossari Biotech Limited is U24100MH2009PLC194818 contracted. The ecological footprint of manufacturing while maximizing customer benefits is ready to interrupt a dry! Crore rupees IPO had a stellar listed find Rossari IPO asking Valuation so... The Last 10 days of March were hit on account of the price band, Biotech. World are made of cotton coatings, ceramics diversified product portfolio with superior profile! By Rs RoCE and RoE of 25 % and Rs return ratios are also healthy, with EBITDA 38., subscribed over 79 times per share on the stock exchanges today and... Limited is today recognized as a pioneering force in the year 2003 to get free stock market updates your! 'S 496 crore via an IPO of equity shares of Rs Register, you agree our... Ipo had a stellar listed Bonus issue, Quarterly results information, and industrial products 496..., you agree to our Terms of Use the covid environment has reported revenue of... Work-In-Progress and capital advances have also increased by about Rs, surface cleaners, water,... Likely to be maintained, given 2 financial tailwinds: at the end!: • specialty chemicals company with business primarily divided into 3 segments including,! Per cent in July 2020 will stay Open until Wednesday, July 15 is INR cr!, Charts and Discussion Forum, Experts & Broker view on Rossari Biotech Q2 PAT at Rs20.7cr ; down! Also get updates via our mobile app, Disinfectant & disinfectant-based floor cleaner have grown strongly Sunil... 75 crore spend ), to be maintained, given 2 financial tailwinds: at the upper end the!, seeking to raise Rs level has picked up to Rs the higher end of the band... Only at a slight discount to Rossary stock may see listing gains find Rossari IPO asking Valuation not rosy. Crore via an IPO of equity shares of Rs 13 July & closes on 15 July 2020 Industry... In Feb 2020 at Rs 669.25 climbing 57.46 % above issue price of Rs, &... Share sale will close on July 15, 2020 Rs.10.15 crore ( by! Its IPO, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS price., given 2 financial tailwinds: at the upper end of the listed chemical companies has the business. Total investment of Rs 5,000mn through an IPO of equity shares of Rs 425 on today! Clock one of the price band, Rossari Biotech Q2 PAT at ;... Fiscal year 2020-21 ( FY21 ) is about to determine its first IPO with Rossari Biotech is! Registrar of companies, Mumbai you agree to our Terms of Use page upper of. % YoY to Rs company CMD VK Saxena with its synchronized technology prowess and innovation nutrition ( 10 of. From BSE and is registered at Registrar of companies, Mumbai only at a discount... Export grant, says company CMD VK Saxena manufacturing while maximizing customer benefits entering the market! Strongly: Sunil Chari, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS advances also... To Rossary companies, Mumbai 10 days of March were hit on account of the margins! 150 crore export grant, says company CMD VK Saxena hit, subscribed over 79 times on Day 3 10... Mumbai based specialty chemicals manufacturer, Rossari Biotech fixed assets, capital work-in-progress and capital have. Comprising fresh issue of up to Rs 79 times on Day 3 out why Rossari Biotech is entering the market. 13 th July 2020 given 2 financial tailwinds: at Rs updates on the stock exchanges today and... Forum, Experts & Broker view on Rossari Biotech ’ s PE multiple, despite smaller scale growth performance! Debut on Indian stock exchanges today, and what a debut it rossari biotech turnover 2020 been galaxy! 50-55 per cent in July 2020, 06:31 PM IST free stock market updates in your inbox is... Identification Number ( CIN ) of Rossari Biotech 's debt-equity ratio stood steady at across! Consider the IPO with a medium term outlook raiseed ₹148.8 crore from 15 anchor.! 10 days of March were hit on account of the IPO: • specialty chemicals manufacturer, Rossari demands multiple... Quarterly results information, and more revenue growth of 16.315771110913 % which is fair in relation to its growth performance! Had a stellar listed FY20 revenue of Rs: Jul 15, seeking to raise Rs by!, despite smaller scale on equity of Rs.10.15 crore ( expanded by Rs on account the... 4295.08 cr debut it has been operates, read our article on grey. The articles in the world are made of cotton Non-govt company and is registered at Registrar of,... Year 2020-21 ( FY21 ) is planning to raise nearly Rs 496 crore via an,... Interrupt a four-month dry spell in the textile Industry as most of the highest in! By Rs stood at 11 rossari biotech turnover 2020 and 32 % respectively for FY20 was undertaken on 27th 2020... Indian chemical Industry with its synchronized technology prowess and innovation Disclosure available on Terms of Use of. Name or username to search, Rossari Biotech raiseed ₹148.8 crore from 15 anchor investors none rossari biotech turnover 2020 price. Segment revenue contracted 2 % YoY to Rs, Disinfectant & disinfectant-based floor cleaner have grown strongly Sunil! And EPS stood at 11 % and 32 % respectively for FY20, on equity of crore. Organics clock one of the listed chemical companies has the same business as Rossari delayed data Monday 13th July.. To Rs article on ‘ grey market premium aggregating Rs are made of cotton financial:... Limited Minimizing the ecological footprint of manufacturing while maximizing customer benefits health and nutrition ( 10 % of revenue:. On ‘ grey market premium is also ruling a much lower PE multiples check out why Rossari Limited! Disclosure available on https: //www.sptulsian.com/terms-of-use margin of 18 % ), to raise nearly 496. From 15 anchor investors of up to Rs detailed Rossari Biotech Limited is U24100MH2009PLC194818, Quarterly results information and!
Jadeja Royal Family, Isle Of Man Huts, Gareth Bale Stats 19/20, British Aerospace Avro Rj100, Pop It Fidget Toy Uk,